Altria Stock Trades Below The Market On Earnings And Above It On Sales

Both readings are true at once, and the gap between them is the real question for anyone weighing the shares.

Altria (MO) trades around $67.90, roughly 9% below its 52-week high of $74.92, after returning 22% over the trailing twelve months. Over the trailing three months it returned 1.1% against 4.2% for the S&P 500.

On earnings it sits well below the market, at 14.2 times earnings against 24.4 for the S&P 500. On sales the order flips: 5.5 times revenue against 3.4 for the index.

How Can One Stock Be Below The Market On Earnings And Above It On Sales?

Because far less is lost between the top line and the bottom than at the average company. Operating margin runs at 60% against 18.4% for the S&P 500, and net margin of 39% against 12.9% for the index leaves roughly $8.0 billion. The business converts about 46% of revenue into operating cash flow versus 22% for the market. The two multiples are one fact seen twice: at a 39% net margin, 14.2 times earnings is 5.5 times sales.

What Is Growing Behind That Margin?

Not much, on the top line. Revenue has shrunk at a 0.4% average annual rate over the last three years, against 5.9% growth for the S&P 500. Revenue of $20.4 billion over the trailing twelve months is barely changed from a year earlier, and in the second quarter of 2026 it grew 1.2% to $5.4 billion. Profitability sits far above the market, on a top line that does not grow.

The Cigarette Business Is Doing The Heavy Lifting

In the second quarter of 2026 adjusted diluted earnings per share rose 2.8% to $1.48. Smokeable products carried it: adjusted operating companies income grew 2.4% to $3 billion at a 65% margin, as price realization of 4.5% ran against inventory-adjusted domestic cigarette volumes that fell 4.5%. The company estimates industry cigarette volumes fell 5%, a fourth straight quarter of moderating declines, and management has narrowed full-year 2026 guidance to adjusted EPS of $5.61 to $5.72, lifting the low end.

Marlboro’s overall retail share fell 1.5 share points from a year earlier as discount retail share grew 2.6 share points, while Marlboro held 60% of the premium segment. By management’s own account the consumer remains under pressure from inflation and elevated gas prices.

What The Nicotine Pouch Push Costs Right Now

Oral tobacco is where the transition is being paid for. Adjusted operating companies income there fell 8% in the second quarter of 2026, and reported on! shipment volume was 49.9 million cans, down 4.2% from a year earlier, while on! PLUS has reached 120,000 stores. The company puts that segment profit decline down to on! PLUS trial investment and a difficult prior year comparison, and the volume decline to trade inventory movements. Reported profit fell in the quarter, with lower nicotine pouch sales offsetting some of the cigarette growth. The counterweight is share: on! retail share reached 8.6%, up 0.8 share points sequentially, with flavor extensions due in the fourth quarter of 2026.

What Has To Hold For The Cash To Keep Coming

None of this resolves into a verdict. The margin is the entire case for the multiple, so watch whether smokeable adjusted operating companies income margin holds near 65% while price realization keeps pace with volume decline. The other half is whether the oral segment’s 8% profit decline is the price of a launch or the shape of the business. And the payout rests on that cash: about $3.6 billion of dividends in the first half of 2026, with debt at 1.9 times EBITDA. Our five-factor stock scorecard scores those pieces against one another.

Owning One Tobacco Franchise Is Still Owning One Category

A business that turns close to half its revenue into cash is a rare thing, and it is still one business in one category, facing one stretched consumer and one long secular decline. Concentration is the risk that never shows up in a multiple. That is the case for a system rather than a single name: the Trefis High Quality portfolio is a rules-based group of stocks, rebalanced on evidence rather than conviction. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.